Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohis Clinical Trials

Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis

Explore clinical trials studying Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis trial results

Recruiting

A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS])

NCT07208058

Conditions: Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
Locations: Beijing Friendship Hospital, Capital Medical University Beijing, Beijing Municipality, China

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

Peking University People's Hospital Beijing, Beijing Municipality, China

Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View all 18 locations

View Trial Details

Related conditions